Opinion
14hon MSNOpinion
We study pandemics, and the resurgence of measles is a grim sign of what’s coming
In the three decades between 1993 and 2024, measles in the U.S. was relatively rare – a few hundred cases each year, at most. But suddenly, the disease has become so entrenched in American life that ...
Coverage initiation surrounding Gilead Sciences highlights renewed market discussion around the biopharmaceutical company. Institutional portfolio adjustments and brokerage commentary place the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results